Archive for ADHD Research Updates

Thirty percent of children with AD/ADHD cannot tolerate taking stimulant medications.

For these individuals, the recent news that Shire is one step closer to gaining FDA approval for its time-released non-stimulant INTUNIV is welcome news.

Read More→

The link between food additives (i.e. preservatives and food coloring) and Attention Deficit Hyperactivity Disorder (ADD or ADHD) has been speculated for a very long time. There has been research for decades on this. The Feingold Diet has been in existence for many years, and postulates that when you eliminate food additives, ADD or ADHD will improve.

Read More→

A new study was just released which documents that Vyvanse works for Adults with ADD and ADHD.
Vyvanse (lisdexamfetamine) is a new medication for ADD and ADHD, which is currently approved for ADHD in children, aged 6-12.
Shire, the makers of Vyvanse, have applied to the FDA for approval for Vyvanse to be indicated in Adults.
This study documents that it works, and will hopefully help to make this medication more available to adults with ADD/ADHD.
To read more details of this new study, click here.

Read More→

Does the health care system have your
best interest at heart when it comes
to treating your ADHD?

Here are some shocking facts about ADHD.

* 1.5 Million Adults take stimulant
medication for ADD/ADHD. 10% of them are
over age 50.

Read More→

When it comes to ADD and ADHD medication, there have been a number of new warnings that have come out in the past two years. I would suggest that one of the most serious is the concern that ADHD medication can cause heart attacks, strokes, or sudden death.

Read More→

A study was just released today documenting a connection between food additives and hyperactivity. It was published in the prestigious medical journal The Lancet. Unfortunately, one has to subscribe to access the full text of the article. However, you can read a summary of it here – in the press release.

Read More→

A research study was just published in the medical journal ‘Sleep‘ which reports on a study of children with attention deficit hyperactivity disorder (ADHD) and poor sleep efficiency. It documents that a measure of vigilance improves when these children use the medication methylphenidate.

Read More→

A new study was reported on in the Syndney Morning Herald, discussing how Melbourne researchers have done brain scans to show how differently children with ADD or ADHD’s brains process information. The story is here.

Read More→

The American Academy of Child and Adolescent Psychiatry just concluded its annual scientific meeting in San Diego.

An important study came out regarding the use of Daytrana, the methylphenidate patch – which is sometimes called the ‘ritalin patch’.

Read More→

At the recent scientific meeting of the American Academy of Child and Adolescent Psychiatry, a study was released which documented that Strattera improved ADHD and Reading Disorder (dyslexia). I will summarize this study here, but if you want to read the full report, please visit here.

Read More→